Platelet-activating factor

被引:6
|
作者
Owen, John S. [1 ]
Thomas, Michael J. [1 ]
Wykle, Robert L. [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27109 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0076-6879(07)34006-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Platelet-activating factor (PAF) is a potent mediator that occurs at very low concentrations in cells and tissues. Accurate quantitation of PAF has always been difficult because of the physicochemical properties of PAF and its structural similarity to several much more abundant phospholipids. Numerous assays for PAF have been developed, all of which have their strengths and limitations. Herein, this chapter describes a high-pressure liquid chromatography (HPLC)tandem mass spectrometry assay for PAF. Major strengths of the method are its sensitivity (detection limit = 1 pg) and selectivity. Another advantage is that, by using liquid instead of gas chromatography, sample derivatization is avoided. The limitations of the method are its use of expensive instrumentation and the requirement of performing two HPLC runs per sample. Detailed technical advice on application of the method to various types of samples is given.
引用
收藏
页码:105 / 116
页数:12
相关论文
共 50 条
  • [21] Platelet-activating factor inhibits the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages
    Narahara, H
    Kawano, Y
    Nasu, K
    Yoshimatsu, J
    Johnston, JM
    Miyakawa, I
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12): : 6029 - 6033
  • [22] PLATELET-ACTIVATING FACTOR METABOLISM IN HUMAN AMNION AND THE RESPONSES OF THIS TISSUE TO EXTRACELLULAR PLATELET-ACTIVATING FACTOR
    BILLAH, MM
    DIRENZO, GC
    BAN, C
    TRUONG, CT
    HOFFMAN, DR
    ANCESCHI, MM
    BLEASDALE, JE
    JOHNSTON, JM
    PROSTAGLANDINS, 1985, 30 (05): : 841 - 850
  • [23] Platelet microparticles: A carrier of platelet-activating factor?
    Iwamoto, S
    Kawasaki, T
    Kambayashi, J
    Ariyoshi, H
    Monden, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (03) : 940 - 944
  • [24] Mammalian platelet-activating factor acetylhydrolases
    Stafforini, DM
    Prescott, SM
    Zimmerman, GA
    McIntyre, TM
    BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1301 (03): : 161 - 173
  • [25] THE ROLE OF PLATELET-ACTIVATING FACTOR IN ASTHMA
    PAGE, CP
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 144 - 152
  • [26] BIOLOGY AND BIOCHEMISTRY OF PLATELET-ACTIVATING FACTOR
    OFLAHERTY, JT
    WYKLE, RL
    CLINICAL REVIEWS IN ALLERGY, 1983, 1 (03): : 353 - 367
  • [27] Neuroprotection by platelet-activating factor antagonism
    Tian, XH
    Bazan, NG
    NEUROPROTECTIVE AGENTS, 2005, 1053 : 455 - 456
  • [28] PLATELET-ACTIVATING FACTOR AND AIRWAY REACTIVITY
    TOWNLEY, RG
    HOPP, RJ
    AGRAWAL, DK
    BEWTRA, AK
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (06) : 997 - 1010
  • [29] Platelet-activating factor and the growth of fibroblasts
    Rougier, F
    Denizot, Y
    MOLECULAR CARCINOGENESIS, 1998, 22 (04) : 221 - 221
  • [30] IMMUNOMODULATORY PROPERTIES OF PLATELET-ACTIVATING FACTOR
    BRAQUET, P
    HOSFORD, D
    LEUKOTRIENES AND PROSTANOIDS IN HEALTH AND DISEASE, 1989, 3 : 130 - 134